BLUESTAR

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke BLUESTAR wurde als Wortmarke am 21.08.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 10. Juli 2023

Markenform Wortmarke
Aktenzeichen 1576494
Länder Australien Kanada China Europäische Gemeinschaft Japan Neuseeland
Basismarke US Nr. 88808694, 24. Februar 2020
Anmeldedatum 21. August 2020
Ablaufdatum 21. August 2030

Markeninhaber

10221 Wincopin Circle, Suite 150
Columbia MD 21044
US

Markenvertreter

1300 19th Street, NW, Suite 300 Washington DC 20036 US

Waren und Dienstleistungen

09 Downloadable computer software for management and treatment of diabetes, cardiac diseases and acute and chronic diseases; downloadable computer software for use in the acquisition, storage, organizing, tracking, sharing, and analysis of medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; downloadable computer software for providing coaching and education in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; downloadable computer software for preparing and delivering reports and analytics relating to medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; downloadable computer software for delivery of medical and physiological data and clinical decision support to healthcare organizations, healthcare providers, and healthcare professionals
42 Software as a service (SAAS) services featuring software for collection of patient data related to medical conditions and providing feedback to patients and physicians; software as a service (SAAS) services featuring software for management and treatment of diabetes, cardiac diseases and acute and chronic diseases; software as a service (SAAS) services featuring software for use in the acquisition, storage, organizing, tracking, sharing, and analysis of medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; software as a service (SAAS) services featuring software for providing coaching and education in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; software as a service (SAAS) services featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the fields of management and treatment of diabetes, cardiac diseases and acute and chronic diseases; software as a service (SAAS) services featuring software for delivery of medical and physiological data and clinical decision support to healthcare organizations, healthcare providers, and healthcare professionals
44 Providing health and medical information in the fields of diabetes, cardiac diseases, and chronic and acute diseases; providing medical and health information in the fields of diabetes, cardiac diseases, and chronic and acute diseases via a website; providing medical and health information for use in the acquisition, storage, organizing, tracking, sharing, reporting and analysis of medical and physiological data in the fields of diabetes, cardiac diseases, and chronic and acute diseases via a website; providing medical data and information of patients for use by healthcare providers and healthcare insurance providers for optimization of health care and population management via a website; medical consultations provided via online chat
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
20. September 2022 2022/38 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
09. Juni 2022 2022/25 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
03. Juni 2022 2022/23 Gaz CA Ablehnung
16. Dezember 2021 2021/50 Gaz JP Ablehnung
11. Juli 2021 2021/29 Gaz NZ Ablehnung
07. Juli 2021 2021/28 Gaz EM Ablehnung
04. Juni 2021 2021/26 Gaz US RAW: Partial Ceasing Effect
20. Mai 2021 2021/22 Gaz CN Ablehnung
11. März 2021 2021/11 Gaz AU Ablehnung
23. Februar 2021 2021/9 Gaz US Korrektur
21. August 2020 2021/5 Gaz US Eintragung

ID: 141576494